In the last trading session, 0.32 million shares of the Predictive Oncology Inc (NASDAQ:POAI) were traded, and its beta was 1.17. Most recently the company’s share price was $1.21, and it changed around -$0.13 or -9.70% from the last close, which brings the market valuation of the company to $8.07M. POAI currently trades at a discount to its 52-week high of $3.76, offering almost -210.74% off that amount. The share price’s 52-week low was $0.55, which indicates that the current value has risen by an impressive 54.55% since then. We note from Predictive Oncology Inc’s average daily trading volume that its 10-day average is 6.56 million shares, with the 3-month average coming to 1.16 million.
Predictive Oncology Inc stock received a consensus recommendation rating of Hold, based on a mean score of 3.00. If we narrow it down even further, the data shows that 0 out of 1 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 1 recommended POAI as a Hold, whereas 0 deemed it a Buy, and 0 rated it as Underweight. Predictive Oncology Inc is expected to report earnings per share of 0 for the current quarter.
Predictive Oncology Inc (NASDAQ:POAI) trade information
Instantly POAI has showed a red trend with a performance of -9.70% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 1.4200 on recent trading dayincreased the stock’s daily price by 14.79%. The company’s shares are currently up 47.56% year-to-date, but still down -11.03% over the last five days. On the other hand, Predictive Oncology Inc (NASDAQ:POAI) is 61.33% up in the 30-day period. We can see from the shorts that 0.15 million shares have been sold at a short interest cover period of 1.26 day(s).
Predictive Oncology Inc (POAI) estimates and forecasts
Predictive Oncology Inc share prices are performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have risen 3.42 percent over the past six months and at a 40.23% annual growth rate that is well above the industry average of 25.20%.
Consensus estimates provided by 1 financial analysts predict the company will bring in an average of 350k in revenue for the current quarter. 1 analysts expect Predictive Oncology Inc to make 1.5M in revenue for the current ending quarter.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 53.33%.
POAI Dividends
Predictive Oncology Inc’s next quarterly earnings report is expected to be released in February.
Predictive Oncology Inc (NASDAQ:POAI)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 2.16% of Predictive Oncology Inc shares, and 4.01% of them are in the hands of institutional investors. The stock currently has a share float of 4.10%. Predictive Oncology Inc stock is held by 17.0 institutions, with ADVISORNET FINANCIAL, INC being the largest institutional investor. By 2024-06-30, it held 0.0023% of the shares, which is about 95.0 shares worth $99.0.
Vanguard Extended Market Index Fund and Fidelity Extended Market Index Fund were the top two Mutual Funds as of Sep 30, 2024 . The former held 69.88 shares worth $84556.0, making up 1.05% of all outstanding shares. On the other hand, Fidelity Extended Market Index Fund held roughly 34.66 shares worth around $41944.0, which represents about 0.52% of the total shares outstanding.
